Literature DB >> 6630478

Comparison of radioimmunoassay and fluorescent polarization immunoassay for quantitative determination of vancomycin concentrations in serum.

B H Ackerman, H G Berg, R G Strate, J C Rotschafer.   

Abstract

A new fluorescent polarization immunoassay (Abbott Laboratories, Diagnostics Division, North Chicago, Ill.) was compared with a standard radioimmunoassay (American Diagnostics Corp., Newport Beach, Calif.) in 34 patients being treated with vancomycin. A total of 123 serum samples were divided and quantitatively analyzed for vancomycin by both assay methods. The results obtained indicated that the two assay methods are comparable (y = 1.01x - 0.81; r = 0.99).

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6630478      PMCID： PMC270950          DOI： 10.1128/jcm.18.4.994-995.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  12 in total

1.  Vancomycin. A second look.

Authors:  A L Esposito; R A Gleckman
Journal:  JAMA       Date:  1977-10-17       Impact factor: 56.272

2.  Comparison of a radioimmunoassay and a microbiological assay for measurement of serum vancomycin concentrations.

Authors:  K B Crossley; J C Rotschafer; M M Chern; K E Mead; D E Zaske
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

3.  Comparison of five methods for the assay of serum gentamicin.

Authors:  R M Ratcliff; C Mirelli; E Moran; D O'Leary; R White
Journal:  Antimicrob Agents Chemother       Date:  1981-04       Impact factor: 5.191

4.  Vancomycin Ototoxicity in patient with normal renal function.

Authors:  P G Traber; D P Levine
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391

5.  Vancomycin quantitation by high-performance liquid chromatography in human serum.

Authors:  J B McClain; R Bongiovanni; S Brown
Journal:  J Chromatogr       Date:  1982-09-10

6.  Sensitive radioimmunoassay for vancomycin.

Authors:  K L Fong; D H Ho; L Bogerd; T Pan; N S Brown; L Gentry; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

7.  In vitro evaluation of a vancomycin radioimmunoassay and observations on vancomycin pharmacokinetics in dialysis patients.

Authors:  R E Polk; A Espinel-Ingroff; R Lockridge
Journal:  Drug Intell Clin Pharm       Date:  1981-01

8.  Vancomycin therapy in patients with impaired renal function: a nomogram for dosage.

Authors:  R C Moellering; D J Krogstad; D J Greenblatt
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

9.  Bioassay for determination of vancomycin in the presence of rifampin or aminoglycosides.

Authors:  C N Walker
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

10.  High performance liquid chromatographic assay of vancomycin in serum.

Authors:  J R Uhl; J P Anhalt
Journal:  Ther Drug Monit       Date:  1979       Impact factor: 3.681
View more
  8 in total

1.  Determination of vancomycin in human serum by high-pressure liquid chromatography.

Authors:  F Jehl; C Gallion; R C Thierry; H Monteil
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

2.  Vancomycin Serum Concentration Monitoring : The Middle Ground is Best.

Authors:  F Marra; B Cairns; P Jewesson
Journal:  Clin Drug Investig       Date:  1996-08       Impact factor: 2.859

3.  Vancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalization.

Authors:  Jack Brown; Kristen Brown; Alan Forrest
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections.

Authors:  Pamela A Moise-Broder; Alan Forrest; Mary C Birmingham; Jerome J Schentag
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 5.  Clinical pharmacokinetics of vancomycin.

Authors:  G R Matzke; G G Zhanel; D R Guay
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

Review 6.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

7.  Utility of Silver-nanoparticles for Nano-fluorimetric Determination of Vancomycin Hydrochloride in Pharmaceutical Formulation and Biological Fluids: Greenness Assessment.

Authors:  Ahmed R Mohamed
Journal:  J Fluoresc       Date:  2022-06-25       Impact factor: 2.525

8.  Development and validation of an HPLC method for the determination of vancomycin in human plasma and its comparison with an immunoassay (PETINIA).

Authors:  Muhammad Usman; Georg Hempel
Journal:  Springerplus       Date:  2016-02-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.